How to buy Harvard Bioscience stock (HBIO)

Harvard Bioscience is a medical instruments & supplies business based in the US. Harvard Bioscience shares (HBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.98 – a decrease of 6.16% over the previous week. Harvard Bioscience employs 391 staff and has a trailing 12-month revenue of around $97.7 million.

Our top picks for where to buy Harvard Bioscience stock

Buy Harvard Bioscience stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Harvard Bioscience stock price (NASDAQ: HBIO)

Use our graph to track the performance of HBIO stocks over time.

Harvard Bioscience shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$1.98
52-week range	$1.99 - $5.44
50-day moving average more info button	$2.29
200-day moving average more info button	$3.02
Wall St. target price	$6.25
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.33

Is it a good time to buy Harvard Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harvard Bioscience price performance over time

Historical closes compared with the close of $2.1 from 2024-12-26

1 week (2024-12-20)	-0.47%
1 month (2024-11-27)	-4.55%
3 months (2024-09-27)	-22.79%
6 months (2024-06-28)	-26.32%

1 year (2023-12-28)	-61.18%
2 years (2022-12-28)	-16.00%
3 years (2021-12-28)	7.19
5 years (2019-12-27)	2.94

Is Harvard Bioscience stock undervalued or overvalued?

Valuing Harvard Bioscience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Harvard Bioscience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Harvard Bioscience's PEG ratio

Harvard Bioscience's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.89. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Harvard Bioscience's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Harvard Bioscience's EBITDA

Harvard Bioscience's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.9 million.

The EBITDA is a measure of a Harvard Bioscience's overall financial performance and is widely used to measure a its profitability.

Harvard Bioscience financials

Revenue TTM	$97.7 million
Gross profit TTM	$62.3 million
Return on assets TTM	-1.98%
Return on equity TTM	-20.4%
Profit margin	-14.57%
Book value	$1.50
Market Capitalization more info button	$90.7 million

TTM: trailing 12 months

Harvard Bioscience share dividends

We're not expecting Harvard Bioscience to pay a dividend over the next 12 months.

Have Harvard Bioscience's shares ever split?

Harvard Bioscience's shares were split on a 1319:1000 basis on 3 November 2013 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1319 shares. This wouldn't directly have changed the overall worth of your Harvard Bioscience shares – just the quantity. However, indirectly, the new 24.2% lower share price could have impacted the market appetite for Harvard Bioscience shares which in turn could have impacted Harvard Bioscience's share price.

Harvard Bioscience share price volatility

Over the last 12 months, Harvard Bioscience's shares have ranged in value from as little as $1.99 up to $5.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harvard Bioscience's is 1.313. This would suggest that Harvard Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Harvard Bioscience overview

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc.

Frequently asked questions

null
What percentage of Harvard Bioscience is owned by insiders or institutions?
Currently 7.766% of Harvard Bioscience shares are held by insiders and 75.99% by institutions. How many people work for Harvard Bioscience?
Latest data suggests 391 work at Harvard Bioscience. When does the fiscal year end for Harvard Bioscience?
Harvard Bioscience's fiscal year ends in December. Where is Harvard Bioscience based?
Harvard Bioscience's address is: 84 October Hill Road, Holliston, MA, United States, 01746 What is Harvard Bioscience's ISIN number?
Harvard Bioscience's international securities identification number is: US4169061052 What is Harvard Bioscience's CUSIP number?
Harvard Bioscience's Committee on Uniform Securities Identification Procedures number is: 416906105